Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins

AIDS Research and Human Retroviruses

Volumn 14, Issue 3, 1998, Pages 275-283

  Leutenegger, C M ^a   Hofmann Lehmann, R ^a   Holznagel, E ^a   Cuisinier, A M ^b   Wolfensberger, C ^a   Duquesne, V ^b   Cronier, J ^b   Allenspach, K ^a   Aubert, A ^b   Ossent, P ^a   Lutz, H ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Virbac SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CAT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOBLOTTING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

EID: 0032501954     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.275     Document Type: Article

References (41)

1. Gardner MB: Simian and feline immunodeficiency viruses: Animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antiviral Res 1991;15:267-286.
2. Bendinelli M, Pistello M, Lombardi S, Poli A, Garzelli C, Matteuci D, Ceccherini-Nelli L, Malvaldi G, and Tozzini F: Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 1995;8:87-112.
3. Stott EJ: Anti-cell antibody in macaques. Nature (London) 1991;353:393.
4. Yamamoto JK, Hohdatsu T, and Olmsted RA: Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol 1993;67:601-605.
5. Siebelink KH, Tijhaar E, Huisman RC, Huisman W, de Ronde A, Darby IH, Francis JH, Rimmelzwaan GF, and Osterhaus AD: Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol 1995;69:3704-3711.
6. Hosie MJ, Osborne R, Reid G, Neil JC, and Jarrett O: Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol 1992;35:191-197.
7. Hosie MJ, Dunsford TH, de Ronde A, Willett BJ, Cannon CA, Neil JC, and Jarrett O: Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine 1996; 5:405-411.
8. Lutz H, Hofmann-Lehmann R, Bauer-Pham K, Holznagel E, Tozzini F, Bendinelli M, Reubel G, Aubert A, Davis D, Cox D, and Young E: FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet Immunol Immunopathol 1995;46:103-113.
9. Hofmann-Lehmann R, Holznagel E, Aubert A, Bauer-Pham K, and Lutz H: FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets. Vet Immunol Immunopathol 1995;46:115-125.
10. Morikawa S, Lutz H, Aubert A, and Bishop DH: Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res 1991;21(1):53-63.
11. Kensil C, Patel U, Lennick M, and Marciani D: Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J Immunol 1991;61:431-437.
12. Freund J: The mode of action of immunological adjuvants. Adv Tuberc Res 1956;7:130.
13. Lafon M, Lafage M, Matinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, and Scott-Algara D: Evidence for a viral superantigen in humans. Nature (London) 1992;358:507-510.
14. Calzolari M, Young E, Cox D, Davis D, and Lutz H: Serological diagnosis of feline immunodeficiency virus infection using recombinant transmembrane glycoprotein. Vet Immunol Immunopathol 1995;46:83-92.
15. Lutz H, Arnold P, Hübscher U, Egberink H, Pedersen NP, and Horzinek MC: Specific assessment of feline T-lymphotropic lentivirus serology. Zbl Vet Med B 1988;35:773-778.
16. Dandekar S, Beebe AM, Barlough J, Phillips T, Elder J, Torten M, and Pedersen N: Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J Virol 1992; 66:4040-4049.
17. Tozzini F, Matteucci D, Bandecchi P, Baldinotti F, Poli A, Pistello M, Siebelink KH, Ceccherini-Nelli L, and Bendinelli M: Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies. J Virol Methods 1992;37:241-252.
18. Pistello M, Menzo S, Giorgi M, Da Prato L, Cammarota G, Clementi M, and Bendinelli M: Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol Cell Probes 1994;8:229-234.
19. Hosie MJ, Osborne R, Willett BJ, Thompson FJ, Neil JC, and Jarrett O: Protection from FIV infection using inactivated virus vaccines. In: Abstracts of the International Symposium on Feline Retrovirus Research, 1993. North Carolina State University, Raleigh, North Carolina, 1993, p. 50.
20. Yamamoto JK, Okuda T, and Ackley CD: Experimental vaccine protection against feline immunodeficiency virus. AIDS Res Hum Retroviruses 1991;7:911-922.
21. Hosie M, Osborne R, Yamamoto JK, Neil JC, and Jarrett O: Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol 1995;69:1253-1255.
22. Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, Wurm FM, Hershberg RD, Cobb EK, and Eichberg JW: Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein SU but not gp160. Nature (London) 1990;345:622-625.
23. Hu S-L, Abrams K, Barber GN, Moran P, Zarlin JM, Langlois AJ, Kuller L, Morton WR, and Benveniste RE: Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp 160. Science 1992;255:456-459.
24. + cytotoxic T lymphocytes in rhesus monkeys. J Immunol 1993;152:5096-5105.
25. Marrack P and Kappler J: The staphylococcal enterotoxins and their relatives. Science 1990;248:705-711.
26. Astoul E, Lafage M, and Lafon M: Rabies superantigen as a Vβ T-dependent adjuvant. J Exp Med 1996;183:1623-1631.
27. Matteucci D, Pistello M, Mazzetti P, Giannecchini S, Del Mauro D, Zaccaro L, Bandecchi P, Tozzini F, and Bendinelli M: Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J Virol 1996;70:617-622.
28. Flynn JN, Beatty JA, Cannon CA, Stephens EB, Hosie MJ, Neil JC, and Jarrett O: Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res Hum Retroviruses 1995;11:1107-1113.
29. Sawyer LSW, Wrin MT, Crawford-Miksza L, Potts B, Wu Y, Weber PA, Alfonso RD, and Hanson DV: Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J Virol 1994;68: 1342-1349.
30. Baldinotti F, Matteucci D, Mazzetti P, Giannelli C, Bandecchi P, Tozzini F, and Bendinelli M: Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J Virol 1994;68:3704-3711.
31. Willen BJ, Flynn JN, and Hosie MJ: FIV infection of the domestic cat: An animal model for AIDS. Immunol Today 1997;18: 182-189.
32. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563.
33. + T cells. Science 1995;270:1811-1815.
34. + T cells. Immunol Today 1996;17:217-224.
35. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Brookes R, Klavinskis L, Jones I, Doyle C, and Ward R: Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med 1996;2(7):767-775.
36. Willett BJ, Hosie MJ, Neil JC, Turner JD, and Hoxie JA: Common mechanism of infection by lentiviruses. Nature (London) 1997;385:587.
37. Baier M, Werner A, Bannert N, Metzner K, and Kurth R: HIV suppression by interleukin-16. Nature (London) 1995;378:563.
38. Holznagel E, Leutenegger CM, Hofmann-Lehmann R, Aubert A, Tompkins M, and Lutz H: CD4 epitope masking induced by vaccination with feline immunodeficiency virus (FIV) Env glycoprotein. Submitted (1998).
39. Leutenegger CM, Huder JB, and Lutz H: Molecular cloning and expression of feline interleukin-16. DNA Sequence (in press).
40. Kaumaya PT, Conrad SF, DiGeorge AM, and Laimore MD: Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1. Leukemia 1995;9(Suppl 1):133-138.
41. Schutten M, Andeweg AC, Bosch ML, and Osterhaus ADME: Enhancement of infectivity of a non-syncytium HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Scand J Immunol 1994;41:18-22.